Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
Rodrigo P. Mello, Mariana V.F. Echegaray, Ana Paula Jesus‐Nunes, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 576-583
Closed Access | Times Cited: 17

Showing 17 citing articles:

Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Konstantinos Ν. Fountoulakis, Athanasios Saitis, Alan F. Schatzberg
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 6
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
Guang Chen, Li Chen, Yun Zhang, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 4, pp. 269-279
Open Access | Times Cited: 42
Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine
David S. Mathai, Sandeep M. Nayak, David B. Yaden, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 827-836
Closed Access | Times Cited: 30
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial
Thomas D. Hull, Matteo Malgaroli, Adam Gazzaley, et al.
Journal of Affective Disorders (2022) Vol. 314, pp. 59-67
Open Access | Times Cited: 35
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study
Igor D. Bandeira, Gustavo C. Leal, Fernanda S. Correia‐Melo, et al.
Journal of Psychiatric Research (2023) Vol. 164, pp. 229-234
Closed Access | Times Cited: 20
A pilot randomized controlled trial of ketamine in Borderline Personality Disorder
Sarah K. Fineberg, Esther Y. Choi, Rosa Shapiro-Thompson, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 7, pp. 991-999
Closed Access | Times Cited: 19
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Igor D. Bandeira, Daniel H. Lins-Silva, Vitor Breseghello Cavenaghi, et al.
Harvard Review of Psychiatry (2022) Vol. 30, Iss. 2, pp. 135-145
Closed Access | Times Cited: 25
Neurobiological and genetic correlates of the dissociative subtype of posttraumatic stress disorder.
Erika J. Wolf, Sage E. Hawn, Danielle R. Sullivan, et al.
Journal of Psychopathology and Clinical Science (2023) Vol. 132, Iss. 4, pp. 409-427
Closed Access | Times Cited: 14
How esketamine influences inflammatory cytokines, cortisol and anhedonia in TRD patients is an open question
Thalles Rodrigues Alves Leite, Déborah Araújo Leitão, Letícia Braga Martins, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Closed Access
Disembodiment and Affective Resonances in Esketamine Treatment of Depersonalized Depression Subtype: Two Case Studies
Pietro Sarasso, Martina Billeci, Irene Ronga, et al.
Psychopathology (2024), pp. 1-12
Closed Access | Times Cited: 3
Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
Adam Włodarczyk, Wiesław Jerzy Cubała, Maria Gałuszko‐Węgielnik, et al.
Medicine (2021) Vol. 100, Iss. 29, pp. e26769-e26769
Open Access | Times Cited: 18
Pharmacological modelling of dissociation and psychosis: an evaluation of the Clinician Administered Dissociative States Scale and Psychotomimetic States Inventory during nitrous oxide (‘laughing gas’)-induced anomalous states
Giulia Piazza, Georges Iskandar, Vanessa E. Hennessy, et al.
Psychopharmacology (2022) Vol. 239, Iss. 7, pp. 2317-2329
Open Access | Times Cited: 10
Evidence for the beneficial effect of ketamine in the treatment of patients with post-traumatic stress disorder: A systematic review and meta-analysis
Thaís Rodrigues de Albuquerque, Luís Fernando Reis Macedo, Gyllyandeson de Araújo Delmondes, et al.
Journal of Cerebral Blood Flow & Metabolism (2022) Vol. 42, Iss. 12, pp. 2175-2187
Open Access | Times Cited: 10
Effects of a dissociative drug on fronto-limbic resting-state functional connectivity in individuals with posttraumatic stress disorder: a randomized controlled pilot study
Sarah K. Danböck, Or Duek, Ziv Ben‐Zion, et al.
Psychopharmacology (2023) Vol. 241, Iss. 2, pp. 243-252
Open Access | Times Cited: 4
Is anti-NMDA receptor encephalitis real? II. Therapeutic challenges
Evgeny V. Snedkov, И.А. Волчек, Ilia V. Lemeshev
Neurology Bulletin (2024) Vol. LVI, Iss. 1, pp. 83-94
Closed Access
Psychometric properties of the 23-Item Clinician Administered Dissociative States Scale (CADSS) in a psychological trauma population
J. Douglas Bremner, David Williamson, Viola Vaccarino
Journal of Affective Disorders (2024) Vol. 364, pp. 249-258
Closed Access
Effects of a Dissociative Drug on Fronto-Limbic Resting-State Functional Connectivity in Individuals with Posttraumatic Stress Disorder: A Randomized Controlled Pilot Study
Sarah K. Danböck, Or Duek, Ziv Ben‐Zion, et al.
(2023)
Open Access
Page 1

Scroll to top